Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001070081-25-000012
Filing Date
2025-02-27
Accepted
2025-02-27 16:32:17
Documents
128
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20241231x10k.htm   iXBRL 10-K 4451767
2 EX-10.34 tmb-20241231xex10d34.htm EX-10.34 172533
3 EX-10.36 tmb-20241231xex10d36.htm EX-10.36 1979
4 EX-10.46 tmb-20241231xex10d46.htm EX-10.46 252402
5 EX-10.47 tmb-20241231xex10d47.htm EX-10.47 797496
6 EX-19.1 tmb-20241231xex19d1.htm EX-19.1 210105
7 EX-21.1 tmb-20241231xex21d1.htm EX-21.1 5067
8 EX-23.1 tmb-20241231xex23d1.htm EX-23.1 11387
9 EX-31.1 tmb-20241231xex31d1.htm EX-31.1 12391
10 EX-31.2 tmb-20241231xex31d2.htm EX-31.2 14690
11 EX-32.1 tmb-20241231xex32d1.htm EX-32.1 7203
12 EX-32.2 tmb-20241231xex32d2.htm EX-32.2 7153
13 GRAPHIC tmb-20241231x10k006.jpg GRAPHIC 23826
14 GRAPHIC tmb-20241231xex10d36g001.jpg GRAPHIC 134750
15 GRAPHIC tmb-20241231xex10d36g002.jpg GRAPHIC 96240
16 GRAPHIC tmb-20241231xex19d1001.jpg GRAPHIC 4117
  Complete submission text file 0001070081-25-000012.txt   20989534

Data Files

Seq Description Document Type Size
17 EX-101.SCH tmb-20241231.xsd EX-101.SCH 114785
18 EX-101.CAL tmb-20241231_cal.xml EX-101.CAL 118090
19 EX-101.DEF tmb-20241231_def.xml EX-101.DEF 512947
20 EX-101.LAB tmb-20241231_lab.xml EX-101.LAB 1060081
21 EX-101.PRE tmb-20241231_pre.xml EX-101.PRE 832618
132 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241231x10k_htm.xml XML 3651986
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35969 | Film No.: 25679610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)